2012-02-14 07:11:12 -

Carl Zeiss Meditec AG /
Carl Zeiss Meditec makes successful start to financial year 2011/2012
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement. 





Revenue up by 13.5 percent year-on-year - Growth in all strategic business units
and reporting regions - Profitability further expanded

JENA/Germany, 14 February 2012
Medical technology company Carl Zeiss Meditec started financial year 2011/2012
(end of reporting period 31.12.2011) with growth of 13.5 percent. The company
generated revenue of EUR 210.3 million in the first quarter (previous year: €
185.2 million). Earnings before interest and taxes (EBIT) increased to 28.3
million euros (previous year: 24.0 million euros).

"I am delighted that we have continued on our solid growth course, in spite of
the volatile environment," says Dr. Ludwin   Monz, President and CEO of Carl Zeiss
Meditec AG.
This growth helped the company to further expand its profitability. The EBIT
margin increased to 13.4 percent (previous year: 13.0 percent).

Carl Zeiss Meditec has a broad business portfolio, ranging from ophthalmology,
through microsurgery, to new applications in radiation therapy. "The growth we
have achieved is testimony to the stable position this puts us in: we once again
increased our revenue in all strategic business units and all reporting
regions," says Monz.

Key figures at a glance
Both the "Microsurgery" and "Surgical Ophthalmology" strategic business
units
contributed to this revenue increase, each achieving growth of 23.3 percent. The
strategic business unit "Ophthalmic Systems" grew by 2.8 percent.

All of Carl Zeiss Meditec's reporting regions developed positively. Revenue in
the "EMEA" region increased by 18.6 percent, in spite of the euro crisis, driven
in particular by business transactions in Eastern Europe. A positive effect was
also made by the first-time consolidation of the acquired business of IMEX in
Spain.

Growing by 14.9 percent, the "Asia/Pacific" region re-affirmed our intensified
business efforts in the dynamically developing countries of this region. China,
in particular, as well as the countries of Southeast Asia, continued to exhibit
strong growth. Development in Japan also continued to be positive.

Revenue in the "Americas" region grew by 7.8 percent. The USA continued to
develop positively, with South America once again contributing double-digit
growth.

Looking to the future with optimism
The broad business model and the global presence of Carl Zeiss Meditec are
helping the company to make a positive development forecast for the long term.
With its company programme, Meditec Excellence and Growth Agenda (MEGA) 2015, it
is focusing on the following success factors: innovation, customer focus, new
markets, a strong team and process excellence. "Particularly in view of the
current imponderables concerning the global economy, I feel that our strategy
equips Carl Zeiss Meditec AG well for the challenges ahead," says Monz. "We are
therefore looking to the future with new determination and shall do everything
in our power to continue on our road to success."


Revenue by strategic business unit
+----------------------+------------------+------------------+-----------------+
|Figures in            |3 Months 2010/2011|3 Months 2011/2012|Change from      |
|EUR '000              |                  |                  |previous year    |
+----------------------+------------------+------------------+-----------------+
|Ophthalmic Systems    |88,200            |90,700            |2.8%             |
+----------------------+------------------+------------------+-----------------+
|Surgical Ophthalmology|19,731            |24,325            |23.3%            |
+----------------------+------------------+------------------+-----------------+
|Microsurgery          |77,313            |95,316            |23.3%            |
+----------------------+------------------+------------------+-----------------+



Revenue by region

+-------------------+------------------+------------------+--------------------+
|Figures in         |3 Months 2010/2011|3 Months 2011/2012|Change from previous|
|EUR '000           |                  |                  |year                |
+-------------------+------------------+------------------+--------------------+
|EMEA               |63,460            |75,271            |18.6%               |
+-------------------+------------------+------------------+--------------------+
|Americas           |68,527            |73,897            |7.8%                |
+-------------------+------------------+------------------+--------------------+
|Asia/Pacific region|53,257            |61,173            |14.9%               |
+-------------------+------------------+------------------+--------------------+


Contact for the press
Petra Rettenmaier, Director Corporate Communications, Carl Zeiss Meditec AG
Phone: +49 36 41 220-331, Email: press@meditec.zeiss.com

Henriette Meyer, Director Investor Relations, Carl Zeiss Meditec AG
Phone: +49 36 41 220-106, Email: investors@meditec.zeiss.com

www.meditec.zeiss.com/press







This announcement is distributed by Thomson Reuters on behalf of 
Thomson Reuters clients. The owner of this announcement warrants that: 
(i) the releases contained herein are protected by copyright and 
    other applicable laws; and 
(ii) they are solely responsible for the content, accuracy and 
     originality of the information contained therein. 
    
Source: Carl Zeiss Meditec AG via Thomson Reuters ONE

[HUG#1585298]